Skip to main content
Download PDF

Docosahexaenoic acid supplementation represses the early immune response against murine cytomegalovirus but enhances NK cell effector function

BMC Immunology volume 23, Article number: 17 (2022) Cite this article

Abstract

Background

Docosahexaenoic acid (DHA) supplementation is beneficial for several chronic diseases; however, its effect on immune regulation is still debated. Given the prevalence of cytomegalovirus (CMV) infection and because natural killer (NK) cells are a component of innate immunity critical for controlling CMV infection, the current study explored the effect of a DHA-enriched diet on susceptibility to murine (M) CMV infection and the NK cell effector response to MCMV infection.

Results

Male C57BL/6 mice fed a control or DHA-enriched diet for 3 weeks were infected with MCMV and sacrificed at the indicated time points postinfection. Compared with control mice, DHA-fed mice had higher liver and spleen viral loads at day 7 postinfection, but final MCMV clearance was not affected. The total numbers of NK cells and their terminal mature cell subset (KLRG1+ and Ly49H+ NK cells) were reduced compared with those in control mice at day 7 postinfection but not day 21. DHA feeding resulted in higher IFN-γ and granzyme B expression in splenic NK cells at day 7 postinfection. A mechanistic analysis showed that the splenic NK cells of DHA-fed mice had enhanced glucose uptake, increased CD71 and CD98 expression, and higher mitochondrial mass than control mice. In addition, DHA-fed mice showed reductions in the total numbers and activation levels of CD4+ and CD8+ T cells.

Conclusions

These results suggest that DHA supplementation represses the early response to CMV infection but preserves NK cell effector functions by improving mitochondrial activity, which may play critical roles in subsequent MCMV clearance.

Peer Review reports

Background

Dietary ω-3 polyunsaturated fatty acids (PUFAs) are abundant in nature and belong to a category of safety supplements that have been linked to a reduced risk for chronic diseases, such as cardiovascular diseases [1], cognitive decline [2] and cancer [3]. ω-3 PUFA supplementation during pregnancy also reduces the risk for premature birth and perinatal death and improves birth weight and neonatal growth and development [4, 5]. Due to these health benefits, ω-3 PUFA supplementation for the prevention of several diseases is increasing [6, 7]. However, the public is still confused about the benefit of ω-3 PUFAs due to contradictory findings regarding their immunosuppressive effects on systems targeting viral or bacterial infections. For example, dietary supplementation with fish oil, enriched in ω-3 PUFAs, has been shown to impair host resistance to Mycobacterium tuberculosis [8] and influenza in mice [9]. However, the lungs of mice whose diets were supplemented with only docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), two main ω-3 PUFAs, had a lower M. tuberculosis bacterial load than those of controls [10, 11]. DHA-derived lipids, such as protectin D1 and protectin D1 isomers, have also been shown to suppress influenza virus replication and promote inflammation resolution [12]. This evidence suggests multifaceted roles for ω-3 PUFAs in the immune response against bacterial or viral infection, warranting further in-depth study.

Cytomegalovirus (CMV), a member of the herpesvirus family, is a widespread virus to which approximately 45–100% of the global population has been exposed [13]. Notably, CMV infection is the most common and serious opportunistic infection in individuals with human immunodeficiency virus infection or patients after hematopoietic stem cell or solid organ transplantation [14]. Congenital CMV infection is the most common viral infection in humans and is a leading cause of neurologic disabilities and hearing loss in children worldwide [15]. Natural killer (NK) cells are a vital component of innate immunity and play critical roles in controlling CMV viral replication; experimental depletion of NK cells leads to unchecked viral replication and increased mortality [16]. In C57BL/6 mice, NK cells undergo a nonselective phase mediated by proinflammatory cytokines and a specific phase driven by signaling via Ly49H, an NK cell activation receptor that can directly recognize the MCMV (Smith and K181)-encoded protein m157 expressed on infected cells. The recognition of Ly49H by its ligand, m157, results in the robust expansion of Ly49H+ NK cells and the persistent elevation of KLRG1, important for NK cell-mediated clearance of MCMV-infected cells in C57BL/6 mice [17]. NK cells also play critical roles in regulating steps of the adaptive immune response, such as T cell activation [18]. However, the effects of DHA supplementation on resistance against MCMV infection and the NK cell response remain largely unknown.

In the current study, we explored the susceptibility of C57BL/6 mice fed a DHA-enriched diet for 3 weeks to MCMV infection and assessed the numbers and maturation of NK cells in each tissue. We also explored the expression of molecules related to NK cell effector function and mitochondrial activity. Here, we show that DHA supplementation led to a reduced response to MCMV at the early but not later stage after infection. In addition, DHA supplementation preserved NK cell effector functions by improving metabolic status and mitochondrial activity, which may play critical roles in MCMV clearance in the later stage of infection.

Results

DHA supplementation inhibited the early but not late response to MCMV infection

Five-week-old C57BL/6 mice were first fed a special DHA-enriched or control diet for 3 weeks to explore the effects of DHA on the susceptibility of mice to MCMV infection. Subsequently, the mice were challenged with 3 × 104 PFU of MCMV in 200 μL of PBS by intraperitoneal injection and sacrificed at days 3, 7 or 21 (Fig. 1A). Weight loss, the virus replication level, the visceral coefficient, and the local tissue mRNA levels of inflammatory cytokines were determined at the indicated time postinfection as the main markers of illness severity following MCMV infection [19, 20]. We found that body weight loss was significantly lower at day 3 but higher at days 5 and 7 after MCMV infection in DHA-fed mice than in control mice. However, there was no significant difference in body weight loss between control and DHA-fed mice at days 9, 14 and 21 after MCMV infection (Fig. 1B).

Fig. 1
figure 1

The effect of DHA feeding on MCMV resistance in C57BL/6 J mice. A Schematic diagram of the experimental design. B Weight loss change in mice fed a DHA-supplemented or control diet at days 0, 3, 5, 7, 9, 14, and 21 after MCMV infection. n = 6, pooled data of 2 independent experiments. C The MCMV Ie-1 DNA level in the spleen (left) and liver (right) at days 3, 7, and 21 after MCMV infection was detected by qPCR, n = 9 at day 3; n = 7 at day 7; n = 6 at day 21. These data were pooled from 2–3 independent experiments. D The tissue/body weight ratio was calculated after weighing the spleen (left) and liver (right) tissues of mice fed a DHA-supplemented or control diet at days 3 and 7 following MCMV infection, n = 7 at day 3; n = 6 at day 7 postinfection. These are pooled data of 2 independent experiments. E H&E staining of the spleen and liver tissue at day 7 post MCMV infection. Histopathological quantification of inflammation in the spleen and liver of control and DHA-fed mice is shown in the lower panel. n = 5 pooled data of 2 independent experiments. Each symbol represents an individual mouse. All experiments were replicated at least 2 times. Error bars represent interquartile ranges *p < 0.05; **p < 0.01

Full size image

The spleen, liver and salivary gland are the main target organs of MCMV after intraperitoneal infection [21], and our data showed that the levels of MCMV Ie-1 DNA were increased in the spleen at day 7 postinfection but not day 3. The levels of MCMV Ie-1 DNA were slightly increased in liver tissues at day 3 and 7 postinfection, but without statistical significance. At the dose of MCMV given, no MCMV Ie-1 DNA was detected at day 21 postinfection in the spleen or liver in either the control or DHA-fed mice (Fig. 1C). Previous studies have revealed that MCMV exhibits protracted replication in salivary glands after acute infection, which peaks at day 14 postinfection in C57BL/6 mice [22]. To this end, we also determined the viral load in the salivary glands at day 14 postinfection. The data showed that the viral loads of the salivary glands were comparable between DHA-fed and control mice (Additional file 1: Fig. S1).

Viral infection is often accompanied by hepatosplenomegaly [23, 24]. Regarding the spleen/body weight and liver/body weight index, neither the spleen/body weight nor the liver/body weight was significantly different between control and DHA-fed mice at day 3 postinfection, but liver/body weight was significantly lower, and spleen/body weight was decreased, in DHA-fed mice compared with control mice at day 7 postinfection (Fig. 1D). Interestingly, in control mice, both spleen/body weight and liver/body weight index were significantly increased at day 7 postinfection compared with day 3 postinfection. When these two indexes at days 3 and 7 postinfection in DHA-fed mice were compared, neither index was dramatically increased in DHA-fed mice compared with control mice (Fig. 1D). H&E staining showed that the pathology of both the spleen and liver was not obviously different between control and DHA-fed mice at day 7 postinfection. We also calculated the pathological scores of the H&E staining for both the spleen and liver, as described by Quatrini et al. [25]. The data showed that the pathological scores of both the spleen and liver showed no significant difference between DHA-fed and control mice (Fig. 1E).

These findings demonstrated that DHA supplementation moderately impaired the early response to MCMV infection without affecting final MCMV clearance at the later stage.

DHA feeding affected NK cell frequency, maturation and selective Ly49H expansion in the response to MCMV infection

As the NK cell number peaks at day 7 after MCMV infection [26], we next explored the homeostasis and maturation of NK cells at day 7 after MCMV infection. We analyzed the proportion and numbers of NK cells in the bone marrow (BM), spleen, peripheral lymph nodes (pLNs), and liver tissue. Compared with those in control mice, the proportion and total numbers of NK cells (CD3−CD19−NK1.1+NKp46+ among CD45+ cells) were significantly decreased in the spleen but not other organs or tissues, although a similar trend without statistical significance was observed in the BM (Fig. 2A).

Fig. 2
figure 2

DHA feeding affected NK cell frequency, maturation and Ly49H+ NK cell expansion during the response to MCMV infection. A Flow cytometric analysis and enumeration of NK cells (CD45+CD3−CD19− NK1.1+NKp46+) in the BM, spleens, pLNs and livers of control versus DHA-fed mice. B Flow cytometric analysis and cumulative frequencies of subpopulations of NK cell (CD3−CD19−NK1.1+NKp46+) subsets based on CD11b and CD27 expression in the BM, spleens, pLNs and livers of control versus DHA-fed mice. C Flow cytometric analysis of the KLRG1+ subsets of NK cells (CD3−CD19−NK1.1+NKp46+) in the BM, spleens, pLNs and livers of control versus DHA-fed mice at day 7 postinfection. D Flow cytometric analysis and enumeration of Ly49H+ subsets of NK cells (CD3−CD19−NK1.1+NKp46+) in the BM, spleens, pLNs and livers of control versus DHA-fed mice at day 7 postinfection. E Cumulative frequencies of NK cell (CD3−CD19−NK1.1+NKp46+) subsets found in the spleens, and livers of control versus DHA-fed mice at day 21 postinfection. For each experiment, n = 4 to 9 pooled from 2–3 independent experiments (A–E). Each symbol represents an individual mouse, and the blue dots and red square represent control and DHA-enriched diet-fed mice, respectively. Error bars represent interquartile ranges; *p < 0.05; **p < 0.01; ***p < 0.001

Full size image

NK cells undergo accelerated phenotypic maturation in response to MCMV infection [26]. When the maturation of NK cells was investigated based on the expression of CD27 and CD11b [27], terminally matured NK cell (CD27−CD11b+) numbers were significantly reduced in the BM, spleen and liver, whereas immature NK cells (CD27+CD11b−) numbers were significantly increased in the spleen and liver of DHA-fed mice compared with control mice (Fig. 2B). We also determined the expression levels of KLRG1, another marker of NK cell terminal maturation [28], and found that it was also elevated on NK cells after MCMV infection [26]. Our data showed that compared with control mice, DHA-fed mice exhibited significantly reduced KLRG1+ NK cells in the BM, spleen and liver (Fig. 2C). Regarding the specific phase driven by Ly49H recognition [17], our data showed that DHA-fed mice had a significantly reduced ratio and total number of Ly49H+ NK cells in the spleen compared with those in control mice (Fig. 2D). However, there was no significant difference in the expression of CD11b, 27, KLRG1 or Ly49H at day 21 postinfection between control and DHA-fed mice (Fig. 2E).

As previous study revealed that daily consumption of 1 g ω-3 PUFA for 6 months resulted in reduced CD3−CD16+CD56+ NK cell numbers in human peripheral blood (pBL) leukocytes [29], we also determined the frequency, maturation and Ly49H expression levels of NK cells in the pBL of both DHA-fed and control mice the day before MCMV infection. The data revealed that 3 weeks of DHA feeding resulted in a reduced frequency of NK cells but without a significant effect on NK cell maturation or the frequency of Ly49H+ NK cells in the pBL (Additional file 1: Fig. S2).

Collectively, these data revealed that DHA supplementation reduced NK cell frequency but had no effect on NK cell maturation at a steady state. During MCMV infection, DHA feeding repressed NK cell maturation and Ly49H+ NK cell expansion in the main organs targeted by MCMV, such as the spleen and liver, at the early stage but not the later stage of MCMV infection.

DHA-fed mice showed an enhanced capacity for IFN-γ production of NK cells and enhanced NK cell cytotoxicity during MCMV infection

Early during the course of infection, NK cells exert antiviral effects through direct toxicity and secretion of IFN-γ [30, 31]. Therefore, we next tested the ratio of IFN-γ+ NK cells after stimulation in vitro with PMA and ionomycin and determined the levels of the NK cell degranulation-related molecules perforin and granzyme B (GZMB) [32]. Our data revealed that the overall proportions and geometric mean fluorescence intensity (gMFI) of IFN-γ-secreting NK cells were increased in DHA-fed mice compared with control mice (Fig. 3A). The overall proportions and gMFI of GZMB, but not perforin, among splenic total NK cells were also increased in DHA-fed mice compared with control mice without any stimulation (Fig. 3B, C).

Fig. 3
figure 3

DHA feeding improved IFN-γ production and degranulation by NK cells in the spleen at day 7 postinfection. A Flow cytometric analysis of the ratio and the geometric mean fluorescence intensity (gMFI) of IFN-γ+ splenic NK cells (CD3−CD19−NK1.1+NKp46+) from control versus DHA-fed mice following stimulation with PMA and ionomycin in the presence of GolgiPlug and GolgiStop for 6 h. B, C Flow cytometric analysis depicting the frequencies and gMFI of perforin (B) and granzyme B (GZMB) (C) by splenic NK cells (CD3−CD19−NK1.1+NKp46+) from control versus DHA-fed mice at day 7 postinfection. D Purified splenic NK cells from both DHA-fed and control mice at day 7 after MCMV infection were cocultured with CTV-labeled YAC-1 (left) or MCMV-infected 3T3 cells (right) for 6 h at the E:T ratio of 16:1. Representative flow cytometry plots of CTV+ singlets are shown on the left. The percentages of NK cell-specific lysis are shown on the right, which were calculated by the following formula: [(% CTV + 7-AAD+ cell specific lysis − %CTV + 7-AAD+ cell spontaneous lysis)/ (100 − % CTV + 7-AAD+cell spontaneous lysis)] × 100. For each experiment, n = 9 pooled from 3 independent experiments (A–C); n = 5 pooled from 2 independent experiments (D). Each symbol represents an individual mouse, and the blue dots and red square represent control and DHA-enriched diet-fed mice, respectively. All experiments were replicated 3 times. Error bars represent interquartile ranges; *p < 0.05; **p < 0.01

Full size image

To further determine whether DHA feeding affects NK cell direct cytotoxicity post-MCMV infection, we sorted splenic NK cells from both DHA fed/unfed mice at day 7 after MCMV infection, and cocultured them with YAC-1 or MCMV-infected NIH-3T3 cells, followed by assaying the apoptosis of target cells. The data showed that the direct cytotoxicity of NK cells against both YAC-1 and MCMV-infected NIH-3T3 cells was enhanced in NK cells from DHA-fed mice, although it only showed statistical significance against YAC-1 (Fig. 3D).

These data suggest that DHA may improve NK cell effector function during MCMV infection.

DHA feeding improved the cellular metabolic status and mitochondrial activity of NK cells during MCMV infection

To explore the potential mechanism underlying the enhanced NK cell effector function induced by in vivo DHA supplementation, we next tested whether DHA feeding interfered with NK cell metabolic status, a basic process critical for facilitating robust NK cell effector functions [33]. NK cell activation results in increases in the rates of both glycolysis and mitochondrial oxidative phosphorylation (OXPHOS). The expression levels of dedicated transporters, including the transferrin receptor CD71 and amino acid transporter CD98 [33], which control cellular access to nutrients, were substantially increased on the surface of NK cells from the DHA-fed mice compared with control mice at day 7 postinfection (Fig. 4A, B). Glucose uptake, indicated by the fluorescent glucose analog 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose (2-NBDG) [34], was also increased in NK cells from the DHA-fed mice compared with control mice at day 7 postinfection (Fig. 4C).

Fig. 4
figure 4

Differences in the cellular metabolic status and mitochondrial activity of splenic NK cells between DHA-fed and control mice at day 7 post-MCMV infection. A–E Flow cytometric analysis and cumulative results depicting the gMFI of CD71 (A) and CD98 (B) and the uptake of 2-NBDG (C), MitoTracker (D) and tetramethylrhodamine, methyl ester (TMRM) (E) by splenic NK cells (CD3−CD19−NK1.1+NKp46+) from control versus DHA-fed mice at day 7 postinfection. For each experiment, n = 7 pooled from 2 independent experiments. Each symbol represents an individual mouse, and the blue dots and red squares represent control and DHA-enriched diet-fed mice, respectively. Error bars represent interquartile ranges; *p < 0.05; **p < 0.01; ***p < 0.001

Full size image

Mitochondria, the essential hub of metabolic activity, are critical for OXPHOS activity and are the powerhouses of immunity [35]. In general, healthy mitochondria generate a proper membrane potential for the movement of substrates from the cytosol into the mitochondrial matrix for OXPHOS [36]. At day 7 postinfection, we found that splenic NK cells from DHA-fed mice had an increased overall mitochondrial content, as indicated by flow cytometric labeling with MitoTracker, but with no effect on mitochondrial membrane potential, as indicated by TMRM staining (Fig. 4D, E).

Overall, these findings suggest an increased overall rate of cellular metabolism and increased mitochondrial activity in NK cells from DHA-fed mice.

DHA feeding impaired the cellularity and activation of T cells in the spleen

As the above data showed that DHA feeding inhibited NK cell expansion, we next determined whether DHA feeding would affect adaptive immune response cells, such as T cells and B cells. The data showed that DHA feeding resulted in reduced proportions and numbers of total T cells and subsets of CD4+ and CD8+ T cells but had no obvious effect on B cell number at day 7 postinfection (Fig. 5A).

Fig. 5
figure 5

The effects of DHA feeding on the cellularity and activation of T and B cells in the spleen at day 7 postinfection. A Flow cytometric analysis and enumeration of total T cells (CD45+CD3−CD19−), CD4+ T cells (CD45+CD3+CD19−CD4+CD8−), CD8+ T cells (CD45+CD3+CD19−CD4−CD8+) and B cells (CD45+CD3−CD19+) in the spleens of control versus DHA-fed mice. B Flow cytometric analysis and cumulative data indicating the expression of CD62L and CD44 in CD4+ T and CD8+ T cells between control and DHA-fed mice. For each experiment, n = 5 to 9 pooled from 2 independent experiments (A, B). Each symbol represents an individual mouse, and the blue dots and red square represent control and DHA-enriched diet-fed mice, respectively. Error bars represent interquartile ranges; *p < 0.05; **p < 0.01; ***p < 0.001

Full size image

To further determine whether DHA feeding affects T cell activation, we measured the ratio of CD62LhiCD44lo cells and CD62LloCD44hi cells, which represent naïve and activated T cells, respectively [37], among CD4+ and CD8+ T cells in both control and DHA-fed mice. We found an increased proportion of CD44loCD62Lhi cells but a decreased proportion of CD62LloCD44hicells among both CD4+ T cells and CD8+ T cells in DHA-fed mice compared with controls (Fig. 5B).

These data demonstrate that DHA feeding also impairs T cell expansion and activation.

DHA feeding did not obviously affect the mRNA expression of inflammatory mediators in the spleens of MCMV-infected mice

Type I IFNs, including IFN-α and IFN-β, are critical for controlling of acute MCMV infection [38, 39], sufficient for the induction of latency immediately upon infection in vitro [40]. Thus, we detected the mRNA levels of both IFN-α and IFN-β in pBL cells following MCMV infection at 12, 24, 48, and 72 h by RT–qPCR. We found that the mRNA expression of both IFN-α and IFN-β was highest at 12 h after MCMV infection in vivo in both DHA-fed and DHA-unfed mice, as previously described [41]. However, only at 48 h after MCMV infection was the mRNA level of IFN-α moderately decreased in the DHA-fed mice, compared with the DHA-unfed mice (Fig. 6A).

Fig. 6
figure 6

The effects of DHA feeding on the mRNA expression of inflammatory mediators at day 3 and day 7 post-MCMV infection. A mRNA levels of IFN-α and IFN-β in the peripheral blood cells of both control and DHA-fed mice following MCMV infection at 12, 24, 48 and 72 h determined by RT–qPCR. B, C mRNA levels of the cytokines and chemokines, including IFN-α, IFN-β, IL-4, IL-6, IL-10, IL-12, TNF-α, CCL-2 and CCL3, in the spleen of both control and DHA-fed mice at days 3 (B) and 7 (C) postinfection were determined by RT–qPCR. Each symbol represents an individual mouse, and the blue dots and red square represent control and DHA-enriched diet-fed mice, respectively. For each experiment, n = 5 to 9 pooled from 3 independent experiments (A–C). Error bars represent interquartile ranges. *p < 0.05; **p < 0.01

Full size image

Coordinated secretion of cytokines and chemokines occurs in the target organ during MCMV infection [38]. To explore whether DHA feeding could influence the expression of various inflammatory mediators, the mRNA levels of these inflammatory mediators in splenic tissue were determined at both days 3 and 7 post-MCMV infection. Our data showed that the mRNA levels of IFN-α, IFN-β, IL-4, IL-6, IL-10, IL-12, CCL-2 and CCL-3 in the spleen were comparable between DHA-fed and control mice at day 3 post-MCMV infection (Fig. 6B). At day 7 post-MCMV infection, only the mRNA levels of IL-4 were moderately increased in the spleens of DHA-fed mice compared with controls (Fig. 6C).

Overall, these data suggest that DHA feeding had a minor effect on the levels of inflammatory cytokines at the early stage of MCMV infection.

Discussion

The effect of dietary ω-3 PUFA supplementation on the body’s antiviral capacity is still under debate. A recent updated meta-analysis revealed that clinical omega-3 fatty acid supplementation is associated with favorable outcomes in patients with sepsis [10]. Additionally, the results of a recent pilot study of 100 patients infected with SARS-CoV-2 suggested that higher levels of two major ω-3 PUFAs, DHA and EPA, are negatively correlated with the risk of COVID-19 mortality [42]. In the current study, we found that supplementation with DHA, the main component of ω-3 PUFAs, led to a reduced acute response to MCMV infection, as indicated by increases in weight loss and MCMV DNA load at day 7 postinfection (i.e., the early stage). However, DHA feeding did not affect the later stage of MCMV clearance in C57BL/6 mice, as indicated by a lack of difference in viral load in the salivary glands at day 14 postinfection. Additionally, the pathological changes in both the spleen and liver and the mRNA levels of inflammatory mediators in the spleen were almost comparable between DHA-fed and control mice at day 3 and day 7 postinfection. These findings suggest that DHA supplementation does not affect the end of MCMV clearance.

The results of one previous double-blind, placebo-controlled study showed that daily consumption of 1 g ω-3 PUFA for six months reduces CD3−CD16+CD56+ NK cell numbers in human pBL leukocytes, which was inversely, correlated with the levels of DHA and EPA in erythrocytes [29]. Consistently, our data revealed that mice fed DHA for 3 weeks showed a reduced NK cells frequency in the pBL at a steady state. However, DHA feeding did not affect NK cell maturation or Ly49H+ NK cell frequency in the absence of MCMV infection. Interestingly, at day 7 postinfection, DHA-fed mice further exhibited inhibited NK cell maturation and Ly49H+ NK cell expansion at this time point. In addition, DHA supplementation also reduced the cell numbers and activation levels of T cells at day 7 postinfection. During influenza virus infection, fish oil feeding also decreased the numbers of NK cells and T lymphocytes in the lungs [9]. Collectively, these data indicate that the reduced NK cell numbers, especially the reduction in terminally differentiated NK cells upon MCMV infection, and reduced T cell activation levels contribute to the reduced acute response to MCMV infection as a result of DHA feeding. The mechanisms of DHA feeding resulting in reduced NK cell numbers at a steady state and impaired NK cell maturation upon MCMV infection warrant further study.

Notably, DHA-fed mice showed increased per cell effector functions in NK cells, indicated by an enhanced capacity for IFN-γ production and direct cytotoxicity, and increased expression of the cytotoxicity-related molecule GZMB on NK cells at day 7 post-MCMV infection. NK cell-derived IFN-γ can directly induce CD4+ T cell differentiation into type I T helper cells, facilitating the control of bacterial or virus infection [18]. NK cell-derived IFN-γ enhances direct NK-dendritic cell interactions, leading to the upregulation of costimulatory molecules on DCs, resulting in enhanced CD8+ T cell effector function. Thus, the enhanced per-cell effector function in NK cells may at least partly compensate for the reduced total NK cell numbers, inhibited maturation and Ly49+ NK cells in the subsequent clearance of MCMV-infected cells at the late stage of MCMV infection.

The increase in per-cell NK cell effector function by DHA feeding could be explained by metabolic reprogramming, a key issue involved in regulating NK cell activation and functional maintenance [33]. Our data showed that the uptake of NK cell nutrients, indicated by the enhanced uptake of the glucose analog 2-NBDG and improved expression of the nutrient receptors CD71 and CD98, was enhanced by DHA supplementation. The mitochondrial mass of NK cells in the mice fed DHA was also significantly improved after MCMV infection compared with that in the control mice. This finding might indicate the direct effect of DHA or its derivatives, such as resolvin D1 (RvD1) produced by 15-LOX and 5-LOX and MCTR1 catalyzed by 12-LOX, on mitochondria. The consumption of DHA or other ω-3 PUFAs could remodel the mitochondrial phospholipidome and target mitochondrial enzymatic activity. For example, DHA acts as an agonist of PPARγ, which can promote mitochondrial biogenesis and induce the expression of genes encoding several key mitochondrial enzymes within mitochondria [43]. Dietary supplementation with fish oil for MCMV infection promoted mitochondrial biosynthesis in the liver cells of male C57BL/6 mice [44]. Both RvD1 and MCTR1 have been reported to improve mitochondrial biogenesis and function induced by multiple adverse factors, such as inflammation or high sugar levels [45,46,47].

Conclusions

In summary, DHA supplementation reduced NK cell numbers at a steady state and impaired maturation upon MCMV infection, which may play an important role in the inhibited early response to MCMV infection. However, DHA feeding preserves NK cell effector functions by improving mitochondrial activity, guaranteeing sufficient subsequent MCMV clearance in the later stage of infection. Therefore, DHA supplementation does not affect the end of MCMV clearance, and it is still acceptable to use DHA supplementation for chronic disease prevention in the context of MCMV infection.

Methods

Animals preparation

Five-week-old male wild-type (WT) C57BL/6J mice were purchased from Hunan Sja Laboratory Animal Co., Ltd. (Changsha, Hunan, China). All mice were housed under specific pathogen-free conditions at the Hunan Children’s Hospital Animal Facility on a 12-h light/dark schedule with free access to food and water. All animal procedures and protocols were approved by the Animal Ethics Committee of Hunan Children’s Hospital and followed the guidelines of the Institutional Animal Care and Use Committees of Hunan Children’s Hospital (Changsha, Hunan, China).

Virus stock preparation

The MCMV strain Smith (VR-1399) was a kind gift from the College of Life Sciences, Hunan Normal University (Changsha, Hunan, China). Stocks of MCMV Smith strain salivary gland extracts were prepared as previously described [48]. The viral titer is expressed in plaque-forming units (PFU)/mL. BALB/c mice were injected intraperitoneally with 5 × 103 PFU virus particles and euthanized 2 weeks later. All mice were sacrificed by cervical dislocation under anesthesia with 2% pentobarbital sodium. The salivary glands were collected and homogenized to obtain initial salivary gland-derived MCMV, and these steps were then repeated at least 3 times to obtain more virulent virus. PFUs were quantitated by a simple plaque-forming cell assay on 3T3 fibroblasts provided by Dr. Chen Ze (College of Life Sciences, Hunan Normal University, Changsha, Hunan, China) as previously described [49].

DHA diet and CMV infection

Five-week-old male C57BL/6J mice consumed a control diet (D200208, Research Diets) or a diet containing DHA at physiological levels (2.48% DHA, D201124, Research Diets) ad libitum for 3 weeks (the ingredients of the diets are listed in Table 1). Following 3 weeks of dietary treatment, the mice were infected with MCMV by intraperitoneal injection (3 × 104 PFU, diluted in 200 μL of PBS). The mice were weighed following infection, and the percent weight loss at days 0, 3, 7, 9, 14 and 21 after MCMV infection was calculated by comparison with the starting weight. Mice were subjected to dislocation under anesthesia by 2% pentobarbital sodium at days 3, 7 or 21 after MCMV infection for subsequent studies.

Table 1 Composition of experimental diets
Full size table

Quantification of MCMV Ie-1 DNA levels in the liver and spleen by real-time quantitative PCR (qPCR)

Ten milligrams of fresh liver and spleen tissues were cut into small pieces and placed in a 1.5-ml microcentrifuge tube. DNeasy Blood & Tissue Kits (QIAGEN, 69504) were used to rapidly purify of the total DNA. The DNA concentration was tested by biodrop (Biodrop uLite PC) for each sample. Real-time qPCR was performed using Bestar® SYBR Green qPCR Master Mix (DBI Bioscience, San Diego, CA, United States) with a Roche LightCycler® 480 II. A standard curve was created by comparing Cq values to 10 serial dilutions of the Ie1 plasmid with R2 = 0.9953 (Additional file 1: Fig. S3). The number of copies (Ie-1) was calculated by comparing the Cq values to the standard curve and dividing by the concentration. The primer sequences specific for the immediate early gene (Ie-1) used for qPCR were designed by Primer Bank and are as follows: MCMV Ie-1 Forward, 5′-GAGTCTGGAACCGAAACCGT-3′ Reverse, 5′-GTCGCTGTTATCATTCCCCAC-3′ [25]. The PCR reaction mixture was adjusted to 10 μL, 5 μL 2 × SYBR Green pro taq HS Premix, 0.2 μM primers, 1 μL DNA extraction, 3.6 μL RNase free water. The amplification program was as follows: 30 s at 95 °C for denaturation, 40 cycles that consisted of a step at 95 °C for 5 s followed by 60 °C for 30 s for annealing and 30 s at 72 °C for extension.

Pathological evaluation of spleen and liver tissues

The liver and spleen were removed at day 7 postinfection and fixed with 10% phosphate-buffered formalin, paraffin-embedded, cut into 4-µm sections, and stained with hematoxylin and eosin, as described previously [50]. The pathological score for each slide was calculated by an anatomopathologist blinded to the sample information, as previously described [25]. Briefly, for grading of spleen inflammation, scores of 0, 1, 2, 3, and 4 were assigned, indicating normal, mild (multifocal pyogranulomas in marginal zones), moderate (locally coalescing pyogranulomas in marginal zones with small necrotic foci), substantial (large and coalescing pyogranulomas throughout the splenic parenchyma with extensive necrotic foci, the periarteriolar lymphoid sheath preserved), and severe (extensive necrotic and pyogranulomatous foci, the periarteriolar lymphoid sheath partially replaced by necrotic and granulomatous inflammation), respectively. For liver inflammation grading, scores of 0, 1, 2, 3, and 4 were assigned, indicating normal, mild (multifocal pyogranulomatous hepatitis with scattered single necrotic hepatocytes); moderate (multifocal to coalescing necrotic and pyogranulomatous hepatitis with intranuclear inclusions in hepatocytes); and substantial (coalescing necrotic and pyogranulomatous hepatitis with intranuclear inclusions in hepatocytes), respectively.

Preparation of single-cell suspensions and counts

Single-cell suspensions were prepared from the BM, spleen, pLNs, liver and pBL as previously described. pBL was treated with erythrocyte lysate. The BM, spleens, pLNs and livers were ground and passed through a 40-μm nylon filter. The obtained liver cells were resuspended in 40% Percoll in RPMI 1640 medium containing 5% FBS and then centrifuged (2000 rpm, 4 °C, 5 min). Cell pellets were resuspended in RPMI 1640 medium containing 5% FBS. The cells from each tissue were counted with an automated cell counter (Countstar IC1000).

Flow cytometry

All antibodies purchased for flow cytometry are listed in Table 2. Standard protocols were followed for flow cytometry, as previously described [51]. All flow cytometry experiments were carried out on a BD LSRFortessa™ cell analyzer, and data were analyzed with FlowJo software.

Table 2 Antibodies for flow cytometry
Full size table

Briefly, to detect surface markers, cells were stained with antibodies in staining buffer (phosphate-buffered saline (PBS) containing 2% mouse serum, 2% horse serum, and anti-CD16/CD32 blocking antibodies) in the dark for 15 min at room temperature. For intracellular IFN-γ staining, cells were stimulated with phorbol 12-myristate 13-acetate (PMA) and ionomycin (eBioscience) plus BD Golgi Plug™ and Golgi Stop™ protein transport inhibitor (BD Biosciences) for 4 h, and the cells were then stained with reagent from a Fixation/Permeabilization Solution Kit (BD Biosciences) following the manufacturer’s instructions.

For intracellular proteins (including granzyme B and perforin), cells were stained with surface antibodies, permeabilized with reagent from a Foxp3/Transcription Factor Staining Buffer Set Kit (eBioscience), and then stained with anti-granzyme B and anti-perforin antibody or isotype-matched control antibody.

To determine the direct cytotoxicity of NK cells in both DHA-fed/unfed mice after MCMV infection, purified NK cells were sorted (purity ≥ 95.0%) from the spleen of both DHA-fed and control mice at day 7 after MCMV infection. YAC-1 cells were labeled with CTV (5 µM, Thermo Fisher Scientific, Waltham, United States) according to the manufacturer’s instructions. After washing, 5000 labeled YAC-1 cells were cocultured with the above purified NK cells for 6 h at an effector-to-target (E:T) ratio of 16:1 [52]. Target NIH-3T3 cells were infected with 3 PFU/cell MCMV [53], and 16 h later, these cells were labeled with CTV followed by coculture with purified NK cells as performed for the YAC-1 cell coculture. Specific lysis of target cells was assessed by staining each sample with 1 µg/ml 7-AAD (BD) and measuring by an LSRFortessa™ cell analyzer. As a control, samples containing only target cells were stained with 7-AAD to measure spontaneous cell death. NK cell cytotoxicity was calculated by the following formula, as previously described: [(% CTV+ 7-AAD+ cell specific lysis − %CTV+ 7-AAD+ cell spontaneous lysis)/(100 − % CTV+ 7-AAD+ cell spontaneous lysis)] × 100 [53,54,55]. All groups were tested in triplicate.

To determine the glucose uptake capacity of NK cells, the cells were cultured with prewarmed (37 °C) RPMI 1640 medium (Life Technologies) containing 100 μM 2-(N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose (2-NBDG, a fluorescent glucose analog) (Invitrogen) for 10 min at 37 °C in the dark.

To determine mitochondrial activity, splenic cells were cultured (37 °C, 30 min) with prewarmed (37 °C) RPMI 1640 medium containing 20 nM MitoTracker® Green FM (Invitrogen) or tetramethylrhodamine ethyl ester (TMRM) (Invitrogen) in the dark.

Quantitation of spleen mRNA cytokine and chemokine levels

Mouse peripheral blood cells were collected 12 h, 24 h, 48 h and 72 h after MCMV infection and treated with red blood cell lysis buffer before RNA extraction with the total RNA purification Micro Kit (NORGEN Cat.35300). The spleens were removed from DHA-fed and control mice at day 7 postinfection. The TRIzol method was used to isolate total RNA, and reverse transcription (RT) was conducted with Evo M-MLV RT Premix for qPCR (Accurate Biology). The mRNA levels of IFN-α, IFN-β, IL-4, IL-6, IL-10, IL-12, TNF-α, monocyte chemotactic protein-1 (MCP-1, also referred to as CCL-2) and macrophage inflammatory protein-1-a (MIP-1α, also called CCL3) were measured using real-time RT-qPCR. The primer sequences we used for IFN-α could simultaneously detect the mRNA expression of four subtype of IFN-α in mouse, including IFN-α1, IFN-α2, IFN-α7, and IFN-α11 [40, 56]. The PCR reaction mixture was adjusted to 10 μL, 5 μL 2 × SYBR Green pro taq HS Premix, 0.2 μM primers, 1 μL DNA extraction, 3.6 μL RNase free water. The amplification program was: 30 s at 95 °C for denaturation, 40 cycles that consists of a step at 95 °C for 5 s followed by 60 °C for 30 s for annealing and 30 s at 72 °C for extension. The Ct values were normalized to the internal control. RNA levels were calculated by the following expression: (2−△Ct). The primer pairs used for RT-qPCR are listed in Table 3.

Table 3 Primers of cytokine and chemokine
Full size table

Statistical analysis

The sample size was 3–9 per group, and two or three independent experiments were performed for each experiment. Statistical analysis was carried out using SPSS 23.0 (Chicago, IL, United States). The data in this study are expressed as the Median with an interquartile range. If the data were normally distributed, an unpaired two-tailed Student’s t-test was used to analyze the differences between two independent groups. Otherwise, a two-tailed Mann–Whitney U test was used to analyze the differences, and differences with a p-value ≤ 0.05 were considered significant. All graphs were generated by GraphPad Prism 8.0 (GraphPad Software Inc., La Jolla, CA, United States).

Availability of data and materials

All data are included in the manuscript. The datasets analyzed in the current study are available from the corresponding author on reasonable request.

Abbreviations

DHA:

Docosahexaenoic acid

NK cells:

Natural killer cells

CMV:

Cytomegalovirus

MCMV:

Murine cytomegalovirus

PUFAs:

Polyunsaturated fatty acids

EPA:

Eicosapentaenoic acid

WT:

Wild-type

PFU:

Plaque-forming units

qPCR:

Real-time quantitative PCR

RT:

Reverse transcription

BM:

Bone marrow

pLNs:

Peripheral lymph nodes

pBL:

Peripheral blood

PBS:

Phosphate-buffered saline

2-NBDG:

2-(N-(7-nitro-benz-2-oxa-1,3-diazol-4-yl) amino)-2-deoxyglucose

TMRM:

Tetramethylrhodamine, methyl ester

OXPHOS:

Oxidative phosphorylation

RvD1:

Resolvin D1

gMFI:

Geometric mean fluorescence intensity

References

  1. Rimm EB, Appel LJ, Chiuve SE, Djousse L, Engler MB, Kris-Etherton PM, et al. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2018. https://doi.org/10.1161/CIR.0000000000000574.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cardoso C, Afonso C, Bandarra NM. Dietary DHA and health: cognitive function ageing. Nutr Res Rev. 2016. https://doi.org/10.1017/S0954422416000184.

    Article  PubMed  Google Scholar 

  3. Dierge E, Debock E, Guilbaud C, Corbet C, Mignolet E, Mignard L, et al. Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects. Cell Metab. 2021. https://doi.org/10.1016/j.cmet.2021.05.016.

    Article  PubMed  Google Scholar 

  4. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010. https://doi.org/10.1001/jama.2010.1507.

    Article  PubMed  Google Scholar 

  5. Middleton P, Gomersall JC, Gould JF, Shepherd E, Olsen SF, Makrides M. Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD003402.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2018. https://doi.org/10.1002/14651858.CD003177.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, et al. International society for nutritional psychiatry research practice guidelines for omega-3 fatty acids in the treatment of major depressive disorder. Psychother Psychosom. 2019. https://doi.org/10.1159/000502652.

    Article  PubMed  Google Scholar 

  8. Paul KP, Leichsenring M, Pfisterer M, Mayatepek E, Wagner D, Domann M, et al. Influence of n-6 and n-3 polyunsaturated fatty acids on the resistance to experimental tuberculosis. Metabolism. 1997. https://doi.org/10.1016/s0026-0495(97)90003-2.

    Article  PubMed  Google Scholar 

  9. Schwerbrock NM, Karlsson EA, Shi Q, Sheridan PA, Beck MA. Fish oil-fed mice have impaired resistance to influenza infection. J Nutr. 2009. https://doi.org/10.3945/jn.109.108027.

    Article  PubMed  Google Scholar 

  10. Nienaber A, Baumgartner J, Dolman RC, Ozturk M, Zandberg L, Hayford FEA, et al. Omega-3 fatty acid and iron supplementation alone, but not in combination, lower inflammation and anemia of infection in mycobacterium tuberculosis-infected mice. Nutrients. 2020. https://doi.org/10.3390/nu12092897.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Jordao L, Lengeling A, Bordat Y, Boudou F, Gicquel B, Neyrolles O, et al. Effects of omega-3 and -6 fatty acids on mycobacterium tuberculosis in macrophages and in mice. Microbes Infect. 2008. https://doi.org/10.1016/j.micinf.2008.08.004.

    Article  PubMed  Google Scholar 

  12. Imai Y. Role of omega-3 PUFA-derived mediators, the protectins, in influenza virus infection. Biochim Biophys Acta. 2015. https://doi.org/10.1016/j.bbalip.2015.01.006.

    Article  PubMed  Google Scholar 

  13. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010. https://doi.org/10.1002/rmv.655.

    Article  PubMed  Google Scholar 

  14. Griffiths P, Reeves M. Pathogenesis of human cytomegalovirus in the immunocompromised host. Nat Rev Microbiol. 2021. https://doi.org/10.1038/s41579-021-00582-z.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Razonable RR, Inoue N, Pinninti SG, Boppana SB, Lazzarotto T, Gabrielli L, et al. Clinical diagnostic testing for human cytomegalovirus infections. J Infect Dis. 2020. https://doi.org/10.1093/infdis/jiz601.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Bukowski JF, Woda BA, Welsh RM. Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol. 1984. https://doi.org/10.1128/JVI.52.1.119-128.1984.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fogel LA, Sun MM, Geurs TL, Carayannopoulos LN, French AR. Markers of nonselective and specific NK cell activation. J Immunol. 2013. https://doi.org/10.4049/jimmunol.1202533.

    Article  PubMed  Google Scholar 

  18. Crouse J, Xu HC, Lang PA, Oxenius A. NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol. 2015. https://doi.org/10.1016/j.it.2014.11.001.

    Article  PubMed  Google Scholar 

  19. Hraiech S, Bordes J, Mege JL, de Lamballerie X, Charrel R, Bechah Y, et al. Cytomegalovirus reactivation enhances the virulence of Staphylococcus aureus pneumonia in a mouse model. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2017. https://doi.org/10.1016/j.cmi.2016.09.025.

    Article  Google Scholar 

  20. Oakley OR, Garvy BA, Humphreys S, Qureshi MH, Pomeroy C. Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus. Clin Exp Immunol. 2008. https://doi.org/10.1111/j.1365-2249.2007.03533.x.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Hsu KM, Pratt JR, Akers WJ, Achilefu SI, Yokoyama WM. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J Gen Virol. 2009. https://doi.org/10.1099/vir.0.006668-0.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lu Y, Liu X, Huang Y, Liao Y, Xi T, Zhang Y, et al. The effects of IL10 and NK cells on the susceptibility to mouse cytomegalovirus in BALB/c mice despite the compensation of IFNgamma. Intervirology. 2018. https://doi.org/10.1159/000493316.

    Article  PubMed  Google Scholar 

  23. Komura T, Kagaya T, Takayama H, Yanagi M, Yoshio T, Sugimoto S, et al. Clinical features and dynamics of T cells-related markers in immunocompetent patients with cytomegalovirus hepatitis. Can J Gastroenterol Hepatol. 2020. https://doi.org/10.1155/2020/8874620.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kagan KO, Hamprecht K. Cytomegalovirus infection in pregnancy. Arch Gynecol Obstet. 2017. https://doi.org/10.1007/s00404-017-4380-2.

    Article  PubMed  Google Scholar 

  25. Quatrini L, Wieduwild E, Escaliere B, Filtjens J, Chasson L, Laprie C, et al. Endogenous glucocorticoids control host resistance to viral infection through the tissue-specific regulation of PD-1 expression on NK cells. Nat Immunol. 2018. https://doi.org/10.1038/s41590-018-0185-0.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Robbins SH, Tessmer MS, Mikayama T, Brossay L. Expansion and contraction of the NK cell compartment in response to murine cytomegalovirus infection. J Immunol. 2004. https://doi.org/10.4049/jimmunol.173.1.259.

    Article  PubMed  Google Scholar 

  27. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009. https://doi.org/10.1182/blood-2008-10-187179.

    Article  PubMed  Google Scholar 

  28. Narni-Mancinelli E, Vivier E. NK cell genesis: a trick of the trail. Immunity. 2012. https://doi.org/10.1016/j.immuni.2012.01.001.

    Article  PubMed  Google Scholar 

  29. Mukaro VR, Costabile M, Murphy KJ, Hii CS, Howe PR, Ferrante A. Leukocyte numbers and function in subjects eating n-3 enriched foods: selective depression of natural killer cell levels. Arthritis Res Ther. 2008. https://doi.org/10.1186/ar2426.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Zuo W, Zhao X. Natural killer cells play an important role in virus infection control: antiviral mechanism, subset expansion and clinical application. Clin Immunol. 2021. https://doi.org/10.1016/j.clim.2021.108727.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Hammer Q, Ruckert T, Romagnani C. Natural killer cell specificity for viral infections. Nat Immunol. 2018. https://doi.org/10.1038/s41590-018-0163-6.

    Article  PubMed  Google Scholar 

  32. Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007. https://doi.org/10.1016/j.immuni.2007.04.010.

    Article  PubMed  Google Scholar 

  33. O’Brien KL, Finlay DK. Immunometabolism and natural killer cell responses. Nat Rev Immunol. 2019. https://doi.org/10.1038/s41577-019-0139-2.

    Article  PubMed  Google Scholar 

  34. Zou C, Wang Y, Shen Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods. 2005. https://doi.org/10.1016/j.jbbm.2005.08.001.

    Article  PubMed  Google Scholar 

  35. Mills EL, Kelly B, O’Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017. https://doi.org/10.1038/ni.3704.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016. https://doi.org/10.1016/j.cell.2016.07.002.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Gerberick GF, Cruse LW, Miller CM, Sikorski EE, Ridder GM. Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol. 1997. https://doi.org/10.1006/taap.1997.8218.

    Article  PubMed  Google Scholar 

  38. Biron CA, Tarrio ML. Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus. Med Microbiol Immunol. 2015. https://doi.org/10.1007/s00430-015-0412-3.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Clement M, Humphreys IR. Cytokine-Mediated Induction and Regulation of Tissue Damage During Cytomegalovirus Infection. Front Immunol. 2019. https://doi.org/10.3389/fimmu.2019.00078.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Holzki JK, Dag F, Dekhtiarenko I, Rand U, Casalegno-Garduno R, Trittel S, et al. Type I interferon released by myeloid dendritic cells reversibly impairs cytomegalovirus replication by inhibiting immediate early gene expression. J Virol. 2015. https://doi.org/10.1128/JVI.01459-15.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Dag F, Dolken L, Holzki J, Drabig A, Weingartner A, Schwerk J, et al. Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog. 2014. https://doi.org/10.1371/journal.ppat.1003962.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Asher A, Tintle NL, Myers M, Lockshon L, Bacareza H, Harris WS. Blood omega-3 fatty acids and death from COVID-19: A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2021. https://doi.org/10.1016/j.plefa.2021.102250.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Sullivan EM, Pennington ER, Green WD, Beck MA, Brown DA, Shaikh SR. Mechanisms by which dietary fatty acids regulate mitochondrial structure-function in health and disease. Adv Nutr. 2018. https://doi.org/10.1093/advances/nmy007.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Rossignoli CP, Dechandt CRP, Souza AO, Sampaio IH, Vicentini TM, Teodoro BG, et al. Effects of intermittent dietary supplementation with conjugated linoleic acid and fish oil (EPA/DHA) on body metabolism and mitochondrial energetics in mice. J Nutr Biochem. 2018. https://doi.org/10.1016/j.jnutbio.2018.07.001.

    Article  PubMed  Google Scholar 

  45. Zirpoli H, Sosunov SA, Niatsetskaya ZV, Mayurasakorn K, Manual Kollareth DJ, Serhan CN, et al. NPD1 rapidly targets mitochondria-mediated apoptosis after acute injection protecting brain against ischemic injury. Exp Neurol. 2021. https://doi.org/10.1016/j.expneurol.2020.113495.

    Article  PubMed  Google Scholar 

  46. Yang Y, Zhu Y, Xiao J, Tian Y, Ma M, Li X, et al. Maresin conjugates in tissue regeneration 1 prevents lipopolysaccharide-induced cardiac dysfunction through improvement of mitochondrial biogenesis and function. Biochem Pharmacol. 2020. https://doi.org/10.1016/j.bcp.2020.114005.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Trotta MC, Pieretti G, Petrillo F, Alessio N, Hermenean A, Maisto R, et al. Resolvin D1 reduces mitochondrial damage to photoreceptors of primary retinal cells exposed to high glucose. J Cell Physiol. 2020. https://doi.org/10.1002/jcp.29303.

    Article  PubMed  Google Scholar 

  48. Beaulieu AM, Sun JC. Tracking effector and memory NK cells during MCMV infection. Methods Mol Biol. 2016. https://doi.org/10.1007/978-1-4939-3684-7_1.

    Article  PubMed  Google Scholar 

  49. Brune W, Hengel H, Koszinowski UH. A mouse model for cytomegalovirus infection. Curr Protoc Immunol. 2001. https://doi.org/10.1002/0471142735.im1907s43.

    Article  PubMed  Google Scholar 

  50. Zhang Q, Deng Y, Lai W, Guan X, Sun X, Han Q, et al. Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation. Sci Rep. 2016. https://doi.org/10.1038/srep30146.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Wang F, Meng M, Mo B, Yang Y, Ji Y, Huang P, et al. Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function. Nat Commun. 2018. https://doi.org/10.1038/s41467-018-07277-9.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Wong P, Wagner JA, Berrien-Elliott MM, Schappe T, Fehniger TA. Flow cytometry-based ex vivo murine NK cell cytotoxicity assay. STAR Protoc. 2021. https://doi.org/10.1016/j.xpro.2020.100262.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Babic M, Pyzik M, Zafirova B, Mitrovic M, Butorac V, Lanier LL, et al. Cytomegalovirus immunoevasin reveals the physiological role of “missing self” recognition in natural killer cell dependent virus control in vivo. J Exp Med. 2010. https://doi.org/10.1084/jem.20100921.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Yao B, Yang Q, Yang Y, Li Y, Peng H, Wu S, et al. Screening for active compounds targeting human natural killer cell activation identifying daphnetin as an enhancer for IFN-gamma production and direct cytotoxicity. Front Immunol. 2021. https://doi.org/10.3389/fimmu.2021.680611.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Yang Q, Zhang S, Wu S, Yao B, Wang L, Li Y, et al. Identification of nafamostat mesylate as a selective stimulator of NK cell IFN-gamma production via metabolism-related compound library screening. Immunol Res. 2022. https://doi.org/10.1007/s12026-022-09266-z.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Lieke T, Steeg C, Graefe SE, Fleischer B, Jacobs T. Interaction of natural killer cells with Trypanosoma cruzi-infected fibroblasts. Clin Exp Immunol. 2006. https://doi.org/10.1111/j.1365-2249.2006.03118.x.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Hashimoto-Kataoka T, Hosen N, Sonobe T, Arita Y, Yasui T, Masaki T, et al. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci U S A. 2015. https://doi.org/10.1073/pnas.1424774112.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Banda NK, Thurman JM, Kraus D, Wood A, Carroll MC, Arend WP, et al. Alternative complement pathway activation is essential for inflammation and joint destruction in the passive transfer model of collagen-induced arthritis. J Immunol. 2006. https://doi.org/10.4049/jimmunol.177.3.1904.

    Article  PubMed  Google Scholar 

  59. Rajasekaran M, Sul OJ, Choi EK, Kim JE, Suh JH, Choi HS. MCP-1 deficiency enhances browning of adipose tissue via increased M2 polarization. J Endocrinol. 2019. https://doi.org/10.1530/JOE-19-0190.

    Article  PubMed  Google Scholar 

  60. Bohn E, Autenrieth IB. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cells. J Immunol. 1996;156:1458–68.

    CAS  PubMed  Google Scholar 

  61. Lienenklaus S, Walisko R, te Boekhorst A, May T, Samuelsson C, Michiels T, et al. PCR-based simultaneous analysis of the interferon-alpha family reveals distinct kinetics for early interferons. J Interferon Cytokine Res. 2008. https://doi.org/10.1089/jir.2008.0082.

    Article  PubMed  Google Scholar 

  62. Miyabe C, Miyabe Y, Bricio-Moreno L, Lian J, Rahimi RA, Miura NN, et al. Dectin-2-induced CCL2 production in tissue-resident macrophages ignites cardiac arteritis. J Clin Invest. 2019. https://doi.org/10.1172/JCI123778.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Reiner SL, Zheng S, Wang ZE, Stowring L, Locksley RM. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med. 1994. https://doi.org/10.1084/jem.179.2.447.

    Article  PubMed  Google Scholar 

  64. Deng Y, Yang Q, Yang Y, Li Y, Peng H, Wu S, et al. Conditional knockout of Tsc1 in RORgammat-expressing cells induces brain damage and early death in mice. J Neuroinflamm. 2021. https://doi.org/10.1186/s12974-021-02153-8.

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This study was supported by funding from the National Key Research and Development Project (No. 2019YFA0111200 to YG; No. 2020YFA0113500 to YoD). This work was also supported by funding from the Natural Science Foundation of Changsha (No. kq2014185 to SW). This study was supported by grants from the Chongqing Science and Technology Commission of China (cstc2019jcyj-msxmX0502). This study was supported by the National Natural Science Foundation of China (Nos. 81922068 and 81874313 to YoD; No. 81900055 to HP). This study was also supported by funding from the Natural Science Foundation of Hunan Province (No. 2021JJ40274 to HP; No. 2020JJ5279 to YaD). This work was also supported by funding from the Science Foundation of Hunan Children's Hospital (2020 and 2021).

Author information

Author notes

  1. Shuting Wu and Lili Wang contributed as co-first author

Authors and Affiliations

  1. Pediatrics Research Institute of Hunan Province, Hunan Children’s Hospital, Changsha, Hunan, People’s Republic of China

    Shuting Wu, Lili Wang, Hongyan Peng, Shuju Zhang, Qinglan Yang, Minghui Huang, Yana Li, Shuzhen Guan, Wenjuan Jiang, Liping Li, Peiwen Xiong & Yafei Deng

  2. Pediatric Intensive Care Unit, Hunan Children’s Hospital, University of South China, Changsha, Hunan, People’s Republic of China

    Shuting Wu, Lili Wang, Hongyan Peng, Shuju Zhang, Qinglan Yang, Minghui Huang, Yana Li, Shuzhen Guan, Wenjuan Jiang, Liping Li, Peiwen Xiong & Yafei Deng

  3. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, 510060, People’s Republic of China

    Shanshan Wang

  4. Institute of Materia Medica, College of Pharmacy, Army Medical University (Third Military Medical University), Chongqing, 400038, People’s Republic of China

    Zhaohui Zhang, Qinghua Bi & Youcai Deng

  5. Southwest Hospital/Southwest Eye Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, People’s Republic of China

    Yuan Gao

  6. Cancer Center, Daping Hospital and Research Institute of Surgery, Army Medical University (Third Military Medical University), Chongqing, 400042, People’s Republic of China

    Zhaoyang Zhong

  7. Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, 221002, People’s Republic of China

    Bo Xu

Authors
  1. Shuting Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shanshan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lili Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongyan Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shuju Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Qinglan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Minghui Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yana Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shuzhen Guan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Wenjuan Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zhaohui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Qinghua Bi
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Liping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Yuan Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Peiwen Xiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Zhaoyang Zhong
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Bo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Yafei Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Youcai Deng
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The work presented was performed in collaboration with all authors. ShuW designed and performed the experiments, analyzed the data, and wrote the manuscript. ShaW and LW performed the experiments and analyzed the data. HP, SZ, QY, MH, YL, SG, WJ, ZZ, and QB performed the experiments. LL, YG, PX and ZZ designed the experiments and edited the manuscript. BX and YaD designed the research, performed the experiments and edited the manuscript. YoD devised the concept, designed the research, supervised the study, and wrote the manuscript.

Corresponding authors

Correspondence to Bo Xu, Yafei Deng or Youcai Deng.

Ethics declarations

Ethics approval and consent to participate

All methods in this current study are reported in accordance with ARRIVE guidelines. The studies involving animal procedures and protocols were approved by the Animal Ethics Committee of Hunan Children’s Hospital, and the ethics committee approval code was HCHLL-2021-70. This study does not involve the use of human data or tissue. All experiments were performed in accordance with relevant guidelines and regulations at Hunan Children’s Hospital. All mice were sacrificed by cervical dislocation under anesthesia with 2% pentobarbital sodium.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary figure 1–3 and supplementary figure legend 1–3.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visithttp://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, S., Wang, S., Wang, L. et al. Docosahexaenoic acid supplementation represses the early immune response against murine cytomegalovirus but enhances NK cell effector function. BMC Immunol 23, 17 (2022). https://doi.org/10.1186/s12865-022-00492-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12865-022-00492-6

Keywords

BMC Immunology

ISSN: 1471-2172

Contact us